<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Intellia Therapeutics, Inc. (NTLA) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/ntla/filings</link>
    <description>Latest company filings for Intellia Therapeutics, Inc. (NTLA) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 19:34:40 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/ntla/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[NTLA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526215740/ntla-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-215740</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526215721/ntla-20260511.htm</link>
      <guid isPermaLink="false">0001193125-26-215721</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000210011926000581/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002100119-26-000581</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526197489/d308328d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-197489</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526197422/d25958dars.pdf</link>
      <guid isPermaLink="false">0001193125-26-197422</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526197355/ntla_defa14a_2026.htm</link>
      <guid isPermaLink="false">0001193125-26-197355</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm</link>
      <guid isPermaLink="false">0001193125-26-197283</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000210012126000395/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002100121-26-000395</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526192361/d37532d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-192361</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526182419/d37532d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-182419</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526179401/d138980d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-179401</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526151300/d65395d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-151300</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000010290926001517/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-001517</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088269/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088269</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088260/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088260</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088258/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088258</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088254/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088254</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088251/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088251</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088241/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088241</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526088236/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-088236</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526085425/d848543d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-085425</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526084309/d101756d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-084309</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526077385/d119130ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-077385</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526076550/ntla-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-076550</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Annual report (10-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526073456/ntla-20260226.htm</link>
      <guid isPermaLink="false">0001193125-26-073456</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000199937126003032/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001999371-26-003032</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-11.]]></description>
      <pubDate>Wed, 11 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000009375126000056/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000093751-26-000056</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-09.]]></description>
      <pubDate>Mon, 09 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000110465926009584/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-009584</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000010290926000156/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000156</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-30.]]></description>
      <pubDate>Fri, 30 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526023387/d29201d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-023387</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526008307/d15047d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-008307</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006294/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006294</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006292/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006292</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006291/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006291</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006288/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006288</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006283/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006283</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006278/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006278</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006275/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006275</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312526006264/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-006264</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525317551/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-317551</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2025-12-12.]]></description>
      <pubDate>Fri, 12 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000196922325001077/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001969223-25-001077</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider sale notice (144) on 2025-12-11.]]></description>
      <pubDate>Thu, 11 Dec 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000199937125017496/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001999371-25-017496</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2025-11-12.]]></description>
      <pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525274596/d12611d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-274596</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525269680/ntla-20250930.htm</link>
      <guid isPermaLink="false">0001193125-25-269680</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525269479/d53244d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-269479</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000110465925106358/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-25-106358</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-04.]]></description>
      <pubDate>Tue, 04 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525256378/d98865d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-256378</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2025-10-29.]]></description>
      <pubDate>Wed, 29 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525250757/d44351d8k.htm</link>
      <guid isPermaLink="false">0001193125-25-250757</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Major company event (8-K) on 2025-10-27.]]></description>
      <pubDate>Mon, 27 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525230424/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-230424</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2025-10-03.]]></description>
      <pubDate>Fri, 03 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[NTLA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1652130/000119312525230420/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-230420</guid>
      <description><![CDATA[Intellia Therapeutics, Inc. filed a Insider trade (4) on 2025-10-03.]]></description>
      <pubDate>Fri, 03 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>